每(mei)經AI快訊(xun)，2022年12月(yue)16日(ri)(ri)上(shang)交(jiao)所(suo)披露：2022年11月(yue)28日(ri)(ri)，北京盛(sheng)諾基醫藥(yao)(yao)科(ke)技(ji)股(gu)(gu)(gu)份(fen)有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)保薦人華西(xi)證券(quan)股(gu)(gu)(gu)份(fen)有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)向(xiang)上(shang)交(jiao)所(suo)提交(jiao)了《華西(xi)證券(quan)股(gu)(gu)(gu)份(fen)有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)關于撤(che)回北京盛(sheng)諾基醫藥(yao)(yao)科(ke)技(ji)股(gu)(gu)(gu)份(fen)有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)首次(ci)公(gong)(gong)(gong)開(kai)發(fa)行(xing)股(gu)(gu)(gu)票(piao)并(bing)在科(ke)創板(ban)上(shang)市申請文件的申請》，申請撤(che)銷對北京盛(sheng)諾基醫藥(yao)(yao)科(ke)技(ji)股(gu)(gu)(gu)份(fen)有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)首次(ci)公(gong)(gong)(gong)開(kai)發(fa)行(xing)股(gu)(gu)(gu)票(piao)并(bing)在科(ke)創板(ban)上(shang)市的保薦。上(shang)交(jiao)所(suo)決定終(zhong)止(zhi)對北京盛(sheng)諾基醫藥(yao)(yao)科(ke)技(ji)股(gu)(gu)(gu)份(fen)有(you)(you)(you)(you)(you)限(xian)(xian)(xian)公(gong)(gong)(gong)司(si)首次(ci)公(gong)(gong)(gong)開(kai)發(fa)行(xing)股(gu)(gu)(gu)票(piao)并(bing)在科(ke)創板(ban)上(shang)市的審核。

更多(duo)新股(gu)分析學習，微信搜索(suo)關注【每經極簡(jian)投研(yan)院】，領取課程福利！

每經頭條（nbdtoutiao）——

(記者 曾健輝)

免責聲明：本文內(nei)容(rong)與數(shu)據僅供參考，不(bu)構(gou)成(cheng)投資建議，使用前核實。據此操作，風險自擔。